Enveda Biosciences Closes $68-million Combined Series B Equity … – Business Wire
Dimension led the round with multiple new institutional investors and significant participation from current investors; Silicon Valley Bank provided the debt facility
Company on track to declare multiple clinical candidates in 2023
BOULDER, Colo.–(BUSINESS WIRE)–Enveda Biosciences today announced that it has closed a $68-million equity and debt financing. Dimension led the Series B round, which included participation by multiple new institutional investors, including FPV, Jazz Venture Partners, Level Ventures, Amino Collective, Allen & Co, and Possible Ventures. All of Enveda’s current major investors, including True Ventures, Lux Capital, Wireframe Ventures, Hummingbird Ventures, and Two Sigma Ventures, also participated in the round.
“Enveda’s record of success demonstrates the relevance of its thesis, the promise of its technology, and the efficiency of Enveda’s distributed model”
Enveda’s novel drug discovery platform uses metabolomics and machine learning to…
The post Enveda Biosciences Closes $68-million Combined Series B Equity … – Business Wire first appeared on SEO, Marketing and Social News | OneSEOCompany.com.
source: https://news.oneseocompany.com/2022/12/21/enveda-biosciences-closes-68-million-combined-series-b-equity-business-wire_2022122137967.html
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.